相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Linc01559 Served as a Potential Oncogene and Promoted Resistance of Hepatocellular Carcinoma to Oxaliplatin by Directly Sponging miR-6783-3p
Shunbin Dong et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2021)
A Phase I Study of Alpha-1,3-Galactosyltransferase-Expressing Allogeneic Renal Cell Carcinoma Immunotherapy in Patients with Refractory Metastatic Renal Cell Carcinoma
Andrew W. Hahn et al.
ONCOLOGIST (2020)
Pan-Tumor Pathologic Scoring of Response to PD-(L)1 Blockade
Julie E. Stein et al.
CLINICAL CANCER RESEARCH (2020)
LINC01559 accelerates pancreatic cancer cell proliferation and migration through YAP-mediated pathway
Changjie Lou et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Genomics and Prognosis Analysis of Epithelial-Mesenchymal Transition in Glioma
Chuming Tao et al.
FRONTIERS IN ONCOLOGY (2020)
Epithelial-mesenchymal transition gene signature is associated with prognosis and tumor microenvironment in head and neck squamous cell carcinoma
Ah Ra Jung et al.
SCIENTIFIC REPORTS (2020)
The Role of Human γδ T Cells in Anti-Tumor Immunity and Their Potential for Cancer Immunotherapy
Yuxia Liu et al.
CELLS (2020)
MicroRNA-508 is downregulated in clear cell renal cell carcinoma and targets ZEB1 to suppress cell proliferation and invasion
Wei Wang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2019)
Novel long non-coding RNA LINC02532 promotes gastric cancer cell proliferation, migration, and invasion in vitro
Cheng Zhang et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2019)
Determining cell type abundance and expression from bulk tissues with digital cytometry
Aaron M. Newman et al.
NATURE BIOTECHNOLOGY (2019)
Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma
Pooja Ghatalia et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Genome-wide profiling of the alternative splicing provides insights into development in Plutella xylostella
Qian Zhao et al.
BMC GENOMICS (2019)
LINC00957 Acted as Prognostic Marker Was Associated With Fluorouracil Resistance in Human Colorectal Cancer
Li Hua Zhang et al.
FRONTIERS IN ONCOLOGY (2019)
THUMPD3-ASI Is Correlated With Non-Small Cell Lung Cancer And Regulates Self-Renewal Through miR-543 And ONECUT2
Jia Hu et al.
ONCOTARGETS AND THERAPY (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Identification of Long Non-Coding RNA Expression Profiles and Co-Expression Genes in Thyroid Carcinoma Based on The Cancer Genome Atlas (TCGA) Database
Yun Zhang et al.
MEDICAL SCIENCE MONITOR (2019)
Role of allergen-specific T-follicular helper cells in immunotherapy
Yin Yao et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Overexpression of ULK1 Represents a Potential Diagnostic Marker for Clear Cell Renal Carcinoma and the Antitumor Effects of SBI-0206965
Jun Lu et al.
EBIOMEDICINE (2018)
Bioorthogonal chemical imaging of metabolic changes during epithelial-mesenchymal transition of cancer cells by stimulated Raman scattering microscopy
Luyuan Zhang et al.
JOURNAL OF BIOMEDICAL OPTICS (2017)
Clear Cell Renal Cell Carcinoma is linked to Epithelial-to-Mesenchymal Transition and to Fibrosis
Lea Landolt et al.
PHYSIOLOGICAL REPORTS (2017)
Immunological Consequences of Epithelial-Mesenchymal Transition in Tumor Progression
Peter J. Chockley et al.
JOURNAL OF IMMUNOLOGY (2016)
Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications
Silvia Juliana Serrano-Gomez et al.
MOLECULAR CANCER (2016)
Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer
Bowen Du et al.
MOLECULES (2016)
pRRophetic: An R Package for Prediction of Clinical Chemotherapeutic Response from Tumor Gene Expression Levels
Paul Geeleher et al.
PLOS ONE (2014)
Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
Wanjuan Yang et al.
NUCLEIC ACIDS RESEARCH (2013)
A flexible R package for nonnegative matrix factorization
Renaud Gaujoux et al.
BMC BIOINFORMATICS (2010)
Long-term safety of sorafenib in advanced renal cell carcinoma: Follow-up of patients from phase III TARGET
Thomas E. Hutson et al.
EUROPEAN JOURNAL OF CANCER (2010)
分享论文
